by Paul Krzyzanowski | May 25, 2016
A few weeks ago, I came across an interesting story about a stem cell company with a peculiar patenting strategy. As I looked into it further, I realized I’d stumbled into a complicated corporate plot that became more incredible with every turn. Endonovo Therapeutics...
by Stacey Johnson | May 6, 2016
Arguably one of the most popular science books ever written is heading to the big screen. Tech Insider calls The Immortal Life of Henrietta Lacks “the most important science book of our time.” And with Oprah Winfrey cast as Henrietta’s daughter, you will be hard...
by Stacey Johnson | Apr 8, 2016
I’ve written about the Canadian Science Writers’ Association (CSWA) before, in a post about good stem cell books for kids. Well, CSWA has just released its Short Lists in the 2015 Science in Society Book Awards competition, and with CBC’s Canada Reads having just...
by Mark Curtis | Feb 22, 2016
Welcome to your update from the clinic for the month of January. It was a quiet month in the clinic. However, we did see some clearances for various clinical studies, including Fate’s ProTmune in GvHD and Pluristem’s PLX-R18 in hematopoietic recovery following bone...
by Mark Curtis | Feb 18, 2016
Welcome to your Cell Therapy Deal Review for the month of January. Things got off to a quick start with a number of cell-based immunotherapy companies announcing deals and research collaborations out of the gate, including a third acquisition by Juno. Juno...
Comments